QLife Investor Relations Material
Latest events
Q3 2023
QLife
Q1 2025
20 May, 2025
Q4 2024
6 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from QLife
Access all reports
Qlife, a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. Its products include Q'sensor 2, a sleep apnea screening device; Medsteth, an auscultation platform; and Qlight 3 System, which is used for checking urine albumin concentration. The company also publishes articles in peer review journals about its products, including publications that focus on the clinical accuracy of its devices compared to independent methods.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
QLIFE
Country
🇸🇪 Sweden